BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1163503)

  • 21. [Intellectual development after relaxing the diet at the age of 5 years in typical phenylketonuria].
    Abadie V; Rey F; Plainguet F; Rey J
    Arch Fr Pediatr; 1992 Nov; 49(9):773-8. PubMed ID: 1300964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of physical development in children with classical phenylketonuria].
    Bushueva TV; Borovik TE; Ladodo KS; Kuzenkova LM; Maslova OI; Gevorkyan AK
    Vopr Pitan; 2015; 84(2):34-43. PubMed ID: 26841554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of a nine-year phenylketonuria (PKU) screening (author's transl)].
    Menne F
    MMW Munch Med Wochenschr; 1975 Jan; 117(2):63-8. PubMed ID: 164621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of early started dietetic treatment on the bioelectric brain activity in children with phenylketonuria].
    Koślacz-Folga A; Cabalska B; Jackowska K
    Neurol Neurochir Pol; 1974; 8(6):815-21. PubMed ID: 4437712
    [No Abstract]   [Full Text] [Related]  

  • 25. Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings.
    Dobson JC; Kushida E; Williamson M; Friedman EG
    Pediatrics; 1976 Jul; 58(1):53-8. PubMed ID: 934784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurological status and psychomotor development of children with phenylketonuria treated early].
    Czochańska J; Wilmowska-Pietruszyńska A; Zorska K; Cabalska B
    Probl Med Wieku Rozwoj; 1979; 8():77-83. PubMed ID: 263530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epilepsy and phenylketonuria: a case description and EEG-fMRI findings.
    Guida M; Pesaresi I; Fabbri S; Sartucci F; Cosottini M; Giorgi FS
    Funct Neurol; 2014; 29(1):75-9. PubMed ID: 25014052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Convulsions in phenylketonuria and the pattern of the bioelectric activity of the brain].
    Koślacz-Folga A; Jackowska K; Czochańska J; Wilmowska A; Borzymowska J
    Neurol Neurochir Pol; 1977; 11(4):407-13. PubMed ID: 895976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [EEG in phenylketonuria].
    Kaláb Z
    Cesk Pediatr; 1976 Oct; 31(10):549-52. PubMed ID: 186199
    [No Abstract]   [Full Text] [Related]  

  • 30. Physical growth in phenylketonuria: II. Growth of treated children in the PKU collaborative study from birth to 4 years of age.
    Holm VA; Kronmal RA; Williamson M; Roche AF
    Pediatrics; 1979 May; 63(5):700-7. PubMed ID: 312490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phenylketonuria. Treatment and developmental control].
    Lluch Fernández MD; Ramos Sánchez I; Marchante Cobos C; Pérez Pérez G; Martínez Martínez JJ; Estefanía Gallardo C
    An Esp Pediatr; 1988 Apr; 28(4):327-30. PubMed ID: 3400943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of cerebral bioelectric activity in children with phenylketonuria treated past the age of 6 months].
    Koslacz-Folga A; Cabalska B; Jackowksa K
    Neurol Neurochir Pol; 1972; 6(5):823-9. PubMed ID: 4655987
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Children with phenylketonuria treated early: basic audiological and electrophysiological evaluation.
    Mancini PC; Durrant JD; Starling AL; Iório MC
    Ear Hear; 2013; 34(2):236-44. PubMed ID: 23038064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of daytime quiet sleep components in early treated phenylketonuric infants.
    De Giorgis GF; Nonnis E; Crocioni F; Gregori P; Rosini MP; Leuzzi V; Loizzo A
    Brain Dev; 1996; 18(3):201-6. PubMed ID: 8836501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurophysiological studies of patients with classical phenylketonuria: evaluation of results of IQ scores, EEG and evoked potentials.
    Coşkun T; Topçu M; Ustündağ I; Ozalp I; Renda Y; Ciğer A; Nurlu G
    Turk J Pediatr; 1993; 35(1):1-10. PubMed ID: 8236512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
    de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
    Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroencephalographic findings in anti-N-methyl-d-aspartate receptor encephalitis in children: A series of 12 patients.
    Yildirim M; Konuskan B; Yalnizoglu D; Topaloglu H; Erol I; Anlar B
    Epilepsy Behav; 2018 Jan; 78():118-123. PubMed ID: 29179102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.